Come up with a name for your new list and we'll add to it:
Athenex raised a round of funding on September 20, 2005. Investors include
Niagara Region Venture Fund.
Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…